Apodaca Coyazo v. Social Security Administration

District Court, D. New Mexico·Decided December 2, 2022·No. 1:21-cv-00583·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO

MARIO APODACA COYAZO,

Plaintiff,

v. Civ. No. 21-583 KK KILOLO KIJAKAZI, Acting Commissioner of Social Security, Defendant.

MEMORANDUM OPINION AND ORDER1 THIS MATTER is before the Court on Plaintiff Mario Apodaca Coyazo’s Motion to Reverse and Remand for a Rehearing with Supporting Memorandum (Doc. 21), filed January 27, 2022. On April 29, 2022, the Acting Commissioner of the Social Security Administration (“Commissioner”) filed a response, and on May 13, 2022, Mr. Coyazo filed a reply. (Docs. 25, 31.) Having meticulously reviewed the entire record and the relevant law, being otherwise sufficiently advised, and for the reasons set forth below, the Court finds that Mr. Coyazo’s motion is well-taken and should be GRANTED. I. BACKGROUND AND PROCEDURAL HISTORY Mr. Coyazo filed this action under 42 U.S.C. § 405(g), seeking reversal of the Commissioner’s decision denying his claims for disability insurance benefits (“DIB”) under Title II of the Social Security Act. (Doc. 21 at 1-3.) Mr. Coyazo is a high school graduate who worked as a natural gas technician for over 30 years. (AR 40-41, 43, 103-04.2) Now 62, Mr. Coyazo suffers

1 Pursuant to 28 U.S.C. § 636(c) and Federal Rule of Civil Procedure 73, the parties have consented to the undersigned to conduct dispositive proceedings and order the entry of final judgment in this case. (Doc. 33.) 2 Citations to “AR” refer to the Certified Transcript of the Administrative Record filed on October 22, 2021. (Doc. 14.) from the severe impairments of degenerative disc disease of the lumbar spine, degenerative joint disease of the left hip, arthralgias, gastroesophageal varices, obesity, hypertension, cirrhosis of the liver, hepatic encephalopathy,3 major depressive disorder, generalized anxiety disorder, psychosis, post-traumatic stress disorder (“PTSD”), bipolar disorder, and panic disorder. (AR 17, 40, 827, 829-32.)

A. Procedural History Mr. Coyazo filed his claim for DIB on February 5, 2016, alleging disability beginning on January 1, 2013, due to cirrhosis, arthritis, depression, esophageal varices, fatigue, schizophrenia, poor memory, and inability to be around people. (AR 114-16, 313.) On June 24, 2016, he amended his alleged onset date to January 1, 2012. (AR 315.) His date last insured is December 31, 2017, (AR 17), and thus the period under consideration is from January 1, 2012, to December 31, 2017. Mr. Coyazo’s claim for DIB was denied initially and upon reconsideration. (AR 114, 147, 175-78, 180-85.) On June 6, 2017, he requested a hearing before an Administrative Law Judge (“ALJ”), which was held in person on September 13, 2018. (AR 34-79, 188-89.) At the hearing, at which Mr. Coyazo was represented by counsel, Mr. Coyazo and a vocational expert (“VE”)

testified. (AR 34-79.) On July 11, 2019, ALJ Lillian Richter issued an unfavorable decision. (AR 151-64.) The Appeals Council subsequently granted Mr. Coyazo’s request for review and, on April 17, 2020, remanded the case to the ALJ. (AR 172-73.) ALJ Richter held a second hearing by telephone on September 24, 2020. (AR 80-113.) Mr. Coyazo was again represented by counsel, and both he and a VE testified. (AR 80-113.) On

3 Hepatic encephalopathy is a “[l]oss of brain function [that] occurs when the liver is unable to remove toxins from the blood.” https://medlineplus.gov/ency/article/000302.htm (last accessed Nov. 29, 2022). Symptoms may include changes in sleep patterns, thinking, personality, mood, or behavior; confusion; forgetfulness; poor concentration or judgment; agitation; excitement; disorientation; drowsiness; slurred speech; and, slowed or sluggish movement. Id. “Chronic forms of the disorder often continue to get worse and come back.” Id. 2 January 19, 2021, the ALJ issued a second unfavorable decision. (AR 15-27.) The Appeals Council denied Mr. Coyazo’s subsequent request for review on May 6, 2021, and this appeal followed. (AR 1-3; Doc. 1.) B. Evidence regarding Mr. Coyazo’s Psychiatric Conditions and Symptoms4 1. Medical Record Evidence Mr. Coyazo received treatment from Scott Jeansonne, D.O., a family practitioner at First

Choice Community Health (“FCCH”) Belen, on 17 occasions between December 18, 2012, and September 25, 2017. (AR 454-57, 524-35, 552-53, 570-73, 640-42, 646-51, 688-89.) Inter alia, Dr. Jeansonne treated Mr. Coyazo for psychiatric conditions and symptoms including low energy, fatigue, depression, depression with psychotic features, major depressive disorder, auditory hallucinations, hypervigilance, paranoia with mild delusions of persecution, psychosis, sleep trouble, hepatic encephalopathy associated with cirrhosis, memory issues, “brain fog,” inability to concentrate or focus, and suicidal ideation. (AR 454, 457, 524, 531, 534-35, 552, 570-73, 640, 646-49, 688-89.) Dr. Jeansonne ordered laboratory tests to monitor Mr. Coyazo’s liver function, (AR 454-55, 524-25, 535, 553, 570, 640, 647, 649), and prescribed medications to treat Mr. Coyazo’s cirrhosis and psychiatric conditions and symptoms, including sertraline,5 quetiapine,6

4 In his motion and reply, Mr. Coyazo limits his arguments to the ALJ’s consideration of his psychiatric conditions and symptoms. (Docs. 21, 31.) Thus, although the Court has reviewed the entire record, it will limit its discussion to the record evidence relevant to these conditions and symptoms. 5 Sertraline, or Zoloft, is used to treat depression, obsessive-compulsive disorder, panic attacks, PTSD, and social anxiety disorder. https://medlineplus.gov/druginfo/meds/a697048.html (last accessed Nov. 29, 2022). 6 Quetiapine, or Seroquel, is used to treat the symptoms of schizophrenia, bipolar disorder, and depression. https://medlineplus.gov/druginfo/meds/a698019.html (last accessed Nov. 29, 2022). 3 lactulose,7 and rifaximin.8 (AR 524, 526, 532, 535, 552-53, 570-73, 646-49, 688-89.) In addition, Mr. Coyazo saw family practitioner Caline Cone, M.D., at FCCH South Broadway in Albuquerque on October 23, 2014. (AR 539-40.) Dr. Cone noted Mr. Coyazo’s positive depression screen as well as occasional chest pain that Mr. Coyazo “attribute[d] to worry about his family.” (AR 539.) She prescribed sertraline for his psychiatric symptoms. (AR 539-40.)

In addition to receiving psychiatric treatment from his family practitioners, Mr. Coyazo also received treatment for hepatic encephalopathy from Margaret Lieberman, M.D., a gastroenterologist at the University of New Mexico Hospital, during the relevant period. (AR 585- 88, 658-60, 702-04.) In July 2016, Dr. Lieberman noted Mr. Coyazo’s “complain[ts] of forgetfulness, irritability, hesitancy in speech[,] and severe fatigue,” (AR 658), and observed “some hesitancy in his speech pattern” and that “he did at one point forget what he had been talking about[.]” (AR 659.) She assessed that his “[h]epatic encephalopathy remains problematic despite maximal tolerated therapy[.]” (AR 659.) In September 2016, Dr. Lieberman wrote that Mr. Coyazo’s hepatic encephalopathy “[a]ppear[ed] to be adequately controlled on rifaximin and

lactulose, but anxiety and depression also appear[ed] to be contributing to his irritability and forgetfulness.” (AR 586.) She referred him to behavioral health services. (AR 586.) In March 2017, Dr. Lieberman assessed that Mr. Coyazo’s “[f]orgetfulness remains a problem on rifaximin and the maximum tolerated dose of lactulose.” (AR 703.) Imaging throughout the relevant period confirmed Mr. Coyazo’s diagnosis of liver cirrhosis. (AR 541, 547, 550, 626-27, 685-86, 729-30.)

Free access — add to your briefcase to read the full text and ask questions with AI

Apodaca Coyazo v. Social Security Administration, (D.N.M. 2022).

Apodaca Coyazo v. Social Security Administration (Apodaca Coyazo v. Social Security Administration) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Watkins v. Barnhart
350 F.3d 1297 (Tenth Circuit, 2003)
Hamlin v. Barnhart
365 F.3d 1208 (Tenth Circuit, 2004)
Langley v. Barnhart
373 F.3d 1116 (Tenth Circuit, 2004)
Grogan v. Barnhart
399 F.3d 1257 (Tenth Circuit, 2005)
Fischer-Ross v. Barnhart
431 F.3d 729 (Tenth Circuit, 2005)
Haga v. Barnhart
482 F.3d 1205 (Tenth Circuit, 2007)
Lax v. Astrue
489 F.3d 1080 (Tenth Circuit, 2007)
Oldham v. Astrue
509 F.3d 1254 (Tenth Circuit, 2007)
Frantz v. Astrue
509 F.3d 1299 (Tenth Circuit, 2007)
Keyes-Zachary v. Astrue
695 F.3d 1156 (Tenth Circuit, 2012)
Groberg v. Astrue
505 F. App'x 763 (Tenth Circuit, 2012)
Flaherty v. Astrue
515 F.3d 1067 (Tenth Circuit, 2008)
Mays v. Colvin
739 F.3d 569 (Tenth Circuit, 2014)
Vigil v. Colvin
805 F.3d 1199 (Tenth Circuit, 2015)